| O.1 | Approval of the consolidated financial statements for the 2013 financial year | For |
| O.2 | Approval of the annual corporate financial statements for the 2013 financial year | For |
| O.3 | Allocation of the 2013 income-Setting the dividend | For |
| O.4 | Regulated agreements and commitments | For |
| O.5 | Review of the compensation owed or paid to Mr. Frederic Oudea, Chairman and CEO for the 2013 financial year | Oppose |
| O.6 | Review of the compensation owed or paid to Mr. Severin Cabannes, Mr. Jean-Francois Sammarcelli and Mr. Bernardo Sanchez Incera, Managing Directors for the 2013 financial year | Oppose |
| O.7 | Review on the compensation paid to the persons referred to in Article L.511-71 of the Monetary and Financial Code | Abstain |
| O.8 | Authorization to bring the variable part of the total compensation of the persons referred to Article L.511-71 of the Monetary and Financial Code up to twice the fixed compensation | For |
| O.9 | Re-elect Robert Castaigne | For |
| O.10 | Elect Lorenzo Bini Smaghi | For |
| O.11 | Authorization granted to the Board of Directors to trade in Company's shares up to 5% of the capital | For |
| E.12 | Delegation of authority granted to the Board of Directors for a 26-month period to increase share capital while maintaining preferential subscription rights | For |
| E.13 | Delegation of authority granted to the Board of Directors for a 26-month period to increase share capital with cancellation of preferential subscription rights via public offering | For |
| E.14 | Authorization granted to the Board of Directors for a 26-month period to increase the number of securities to be issued in case of oversubscription during a capital increase | Oppose |
| E.15 | Delegation of authority granted to the Board of Directors for a 26-month period to increase share capital up to 10% of capital and within the ceilings | Oppose |
| E.16 | Delegation of authority granted to the Board of Directors for a 26-month period to issue subordinated bonds convertible into shares of the Company | Oppose |
| E.17 | Delegation of authority granted to the Board of Directors for a 26-month period to carry out capital increases or sales of shares with cancellation of preferential subscription rights | For |
| E.18 | Authorization granted to the Board of Directors for a 26-month period to allocate free performance shares existing or to be issued | Oppose |
| E.19 | Authorization granted to the Board of Directors to cancel treasury shares of the Company up to 5% per 24-month period | For |
| E.20 | Powers to carry out all legal formalities | For |
